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Abstract  
Objectives: Brain injury may cause different 
physical and psychological problems, with 
depression being one of the commonest illnesses 
associated with brain injury. The aim of this research 
study is to analyse the effectiveness of non-
pharmacological therapies in the treatment of 
depression in patients following brain injury. Study 
Design: This is a meta-analysis comparing 
pharmacological and non-pharmacological treatment 
of depression in patients with brain injury. Methods: 
Electronic data-base search, hand searching of 
journals and snowballing method was used to collect 
relevant data for the study. The only studies that 
have focused on treatment of depression in brain 
injury patients between the age of 16 - 64 years were 
included in this research. Results: Data analysis 
indicated that both modes of treatment are effective. 
There was no significant difference between 
pharmacological studies (pooled effect size d+ value 
is -0.37) and non-pharmacological studies (pooled 
effect size d+ value of -0.48). Test for heterogeneity 
is significant for both sets of data and no publication 
bias is detected for included studies. Conclusion: 
The results of the study suggest there is no 
difference in the efficacy of alternative therapies and 
pharmacological treatments for depression in 
patients with brain injury. 
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Introduction 
Mental health particularly depression has long been 
high on the government and public health agenda 
(Cassano and Fava, 2002).  Treatment of depression 
within the community settings is favored by 
professionals avoiding unnecessary admissions to 
the hospital, with teams such as primary care and 
home treatment teams working in the community to 
treat those with depression (Gater, et al, 2010). 
Depression as a consequence of brain injury has 
specific characteristics and additional issues that 
may be particularly well treated within community 
settings.  
Head injury is one of the most common causes of 
brain injury with 171,600 admissions to hospitals in 
England with a primary diagnosis of head injury 
between 2012 and 2103 (Health and Social Care 
Information Centre, 2013).
 
The epidemiology of 
admission indicates 70% are males with an 
increasing number of patients admitted with head 
injuries aged ≥75 years (approaching 40%). 
Additionally 33-50% are children under 15 years of 
age (National Institute for Health and Care 
Excellence, 2014). Severe traumatic brain injury 
defined as Glasgow Coma Score (GCS) <9, has a 
bimodal presentation - 15-25 years and 65-75 years. 
This occurs in 11,000 people per year and has a 
mortality rate reaching 50% (Hammell and Henning, 
2009). It is also known that admissions for head 
injury are from socioeconomically deprived areas 
(Tenant, 2005). 
A person with acquired brain injury is more at risk 
of developing depressive illness during or after 
recovery (Babin, 2003). This occurrence could be 
due to stress and loss of ability to perform daily 
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routine life activities on the same scale prior to the 
brain injury. It is often noticed that people who have 
suffered from brain injury may also experience 
emotional distress and it is possible for those people 
to develop depressive illness (Fann, Uomoto and 
Katon, 2000; Fedoroff, et al, 1992; Hassan, et al, 
2002).  Other symptoms of depression often noticed 
in patients with brain injury include losing interest in 
daily activities, disturbed sleep pattern and eating 
disorder (Khan-bourne and Brown, 2003).  
Antidepressants have been prescribed for a number 
of years by clinicians to treat depression and 
‘tricyclic antidepressants’ (TCAs), ‘monoamine 
oxidase inhibitors’ (MAOIs) and ‘selective serotonin 
reuptake inhibitors’ (SSRIs) are commonly used 
antidepressants prescribed in clinical practice 
depending upon the severity and symptoms of the 
individual (Alderfer, Arciniegas and Silver, 2005; 
Berkow et al., 1997; Collier, Longmore and Scally, 
2003) .  On the other hand, non drug therapies work 
in a different way with a decrease in symptoms of 
depression being achieved by building self-efficacy 
(Bandura , 1982) and personal motivation (Bandura 
and Schunk, 1981).  Self efficacy is achieved 
through extensive learning, social experiences and 
determination of changing behaviour (Bandura, 
1989). In addition, believing in one’s own 
capabilities to make positive changes plays a 
significant role that will assist in overcoming stress 
and depression through change in behaviour 
(Bandura, 1993; Zimmerman, Bandura and 
Martinez-Pos, 1992).   
The non drug studies included in the meta analysis 
act to build self-efficacy in a number of ways. For 
example, Ouellet (2009) reports on the impact of 
volunteering, Powell (2002) investigates a 
community based outreach treatment from a 
multidisciplinary team involving clinicians, 
psychologists and social workers, and the impact of 
building coping mechanisms is discussed by Finest 
(2002).  Other non drug treatments included in the 
meta-analysis are music therapy (Guetin, et al, 2009) 
and residential reintegration (Geurtsen, et al, 2008). 
Antidepressants are not the best choice of treatment 
for depression in patients with brain injury due to the 
side effects of the drugs such as fatigue, loss of 
libido, sedation, poor concentration and toxicity of 
the drug (Brown, 2004). Furthermore, people with 
acquired brain injury are more prone to the side 
effects due to the structural and hormonal changes 
resulting from the injury. Therefore, alternative 
therapies should be considered for the treatment of 
depression in patients with brain injury (Brown, 
2004). Choice of treatment for depression after brain 
injury should also be based upon the individual and 
their needs as to which form of therapy is best 
suitable (Fann et al, 2009). As the majority of people 
experiencing depressive illness who have acquired 
brain injury report a preference for non 
pharmacological treatment (Fann et al, 2009), it 
would therefore be beneficial to investigate the 
efficacy of alternative methods of treating 
depression in patients with brain injury. 
This article aims to investigate and compare the 
efficacy of pharmacological and non 
pharmacological treatments for the treatment of 
depression following brain injury. As stated 
pharmacological treatments may not always be the 
best choice given that they work by adjusting 
hormone and neurotransmitter levels which may be 
disrupted as a consequence of the injury.  Likewise 
non pharmacological treatments may be effective as 
they work on building confidence in competence 
which allows the patient to address the underlying 
behavioural causes of the depression.  
Methods 
This study was a meta analysis seeking to pool 
results from previously published work in order to 
compare efficacy of pharmaceutical and non 
pharmaceutical treatments of depression in patients 
with brain injury. A comprehensive electronic search 
of databases for the relevant literature was carried 
out. In addition, hand searching of material and 
snowballing method was also utilised to identify 
relevant literature.  
Selection Criteria 
The following selection criteria were applied to 
studies identified in the database search; studies 
from peer reviewed journals published within the 
last 10 years, persons who have suffered brain injury 
with a diagnosis of depression, age 16 - 64 years, 
and studies reporting pre and post study depression 
scores in treatment and control groups.   
Data extraction 
Standard deviation and mean of depression score 
were extracted from the selected studies as these 
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represent effect size. All but two included studies 
reported mean and standard deviation. Two studies 
(Ouellet, Morin and Lavoie, 2009; Powell, Heslin 
and Greenwood, 2002) reported mean and standard 
error. Thus standard deviation for these two studies 
was calculated from standard error using the formula 
described below: (Higgins and Green, 2009).
 
  
Where two different treatment and control groups 
were reported within the same study, two different 
sets of data were extracted for analysis.   
Data synthesis 
Once the relevant data had been extracted from the 
studies selected for Meta analysis, this data was 
imported in the software named StatsDirect, version 
2.7.8 for further analysis.  
Results 
Initially 1932 studies were found through database 
search. After eliminating duplicate studies (921), 
step by step inclusion criteria was applied to the rest 
of the studies and finally 24 studies were selected. 
Following further scrutiny of the studies 9 were 
excluded. In the remaining 15 studies the total 
number of participants receiving either drug or non 
drug treatment was 538, with 564 participants in the 
control group. 
Effect size: meta-analysis of drug data 
Six studies with a total of 150 patients had 
antidepressant drug treatment. All studies included 
in the analysis indicate that antidepressants are 
effective for treating depression following brain 
injury. Meta analysis results reveal pooled effect (d+ 
= -0.37, CI= -0.610725 to -0.137906) and overall 
effect (Z-3.103281, p = 0.0019) suggesting that the 
use of antidepressants in the treatment of depression 
following brain injury is effective.  Heterogeneity (I
2 
= 86.5%, Q = 36.98, p <0.0001) is at significant 
level and no publication bias (Kendall’s tau = -0.6, p 
= 0.0556) is detected. 
The forest plot in Figure 1 shows these results.  The 
vertical dotted line in the graph (to the left of the line 
of 0) represents the center of 95% CI range of 
pooled effect size.   
Effect size meta-analysis plot [fixed effects]
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Figure 1: Effect size Meta analysis forest plot for 
drug data 
As can be seen in Figure 1, most of the studies are 
plotted nearby vertical dotted line (to the left of 0). 
Whilst the 95% CI for included studies may span the 
solid vertical line of 0 (no effect) the pooled effect 
size CI (D+ -.0610725 to -0.137906) does not cross 
the line of no effect allowing us to conclude the 
overall efficacy of drug treatment.  
Effect size: meta analysis of non drug data 
In 12 studies, a total 388 patients with depression 
and brain injury have received different types of non 
drug treatment therapies to manage depression.  All 
but one of the studies (Powell, Heslin and 
Greenwood, 2002) indicates that non drug 
treatments are effective in the treatment of 
depression following brain injury.   
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Effect size meta-analysis plot [fixed effects]
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Figure 2: Effect size meta analysis forest plot for 
non drug data 
Combining the results of the 12 included studies 
yields a pooled effect (d+ = -0.48, CI = -0.626614 to 
- 0.341297) and overall effect (Z -6.649008, p = 
0.0001) indicating the efficacy of non drug therapies 
in the treatment of depression following brain injury. 
As with the analysis of studies investigating drug 
treatment, whilst the 95% CI for included studies 
may span the solid vertical line of no effect, the 
pooled effect size CI (-0.626614 to - 0.341297) does 
not cross the line of no effect allowing us to 
conclude the overall efficacy of non drug treatment.  
Statistical test for heterogeneity is significant (I
2 
= 
47.6%, Q = 20.99, P = 0.0334) and no publication 
bias is detected (Kendall’s tau = -0.09, p = 0.6384). 
Comparison of drug and non drug data analysis 
In order to answer the main question to compare 
efficacy of drug and non drug treatments in the 
treatment of depression following brain injury, the 
outcomes of the two meta analyses were compared. 
This was achieved by examining the difference of 
mean between the two treatment groups to advocate 
the effectiveness of treatment with one or the other 
method (Higgins and Green, 2009). In this case 
standardised mean difference (SMD) which is 
Hedges-Olkin g statistic (StatsDirect, 2009) is taken 
into account for the comparison of two treatment 
groups. SMD can be calculated for each study by 
dividing the difference of two means with standard 
deviation, and allows comparison of means when the 
mode of measurement differs as in the measurement 
of depression.   
Table 1 compares SMD of non drug and drug data. 
Stratum refers to the study number in the two sets of 
meta analysis; the table also contains a column for 
SMD with 95% CI for each of the included studies.   
Table 1: Comparison of drug and non drug SMD 
 
In order to determine the most effective treatment, a 
comparison of SMD seen in Table 1 is made. Higher 
scores represent more severe depression whilst 
lower scores suggest mild depression.  
It can be seen from Table 2 that in the majority of 
cases, studies reporting non drug treatments report 
lower SMD. However, this on its own is not 
sufficient to assess the difference between the two 
treatment groups.    
 
 
 
 
 
Stratum g (SMD)  
non 
drug 
data 
95% CI g (SMD)  
drug 
data 
95% CI 
1 -0.32839 -
1.295168 
0.650662 -
0.258961 
-
0.873474 
0.358725 
2 -
0.670442 
-
1.028459 
-
0.310327 
-
3.654407 
-
4.834049 
-
2.451611 
3 -
1.074094 
-
2.388784 
0.296508 -
0.025866 
-
0.387988 
0.336543 
4 -1.44588 -
2.833926 
0.008401 -
1.333401 
-
2.296117 
-
0.340436 
5 -
0.396379 
-
0.729338 
-
0.062137 
-
0.068111 
-
0.944706 
0.809906 
6 -
0.601875 
-
1.177267 
-
0.019524 
-
0.376323 
-
0.846726 
0.096739 
7 -
0.379758 
-
1.151427 
0.40056  
8 -
0.461092 
-
1.447828 
0.541793 
9 -
0.684461 
-
1.008759 
-
0.358283 
10 -
0.592886 
-
0.948025 
-
0.235624 
11 0.289432 -
0.117799 
0.69493 
12 -
1.199938 
-
2.149089 
-
0.222795 
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Table 2: Comparison of drug and non drug data 
Meta analysis results 
Results 
Drug 
data 
Non drug 
data 
Fixed effects 
(Hedges-Olkin) 
Pooled effect size d+ 
-0.374316 
(95% 
CI= -
0.610725 
to -
0.137906) 
-0.483956 
(95% CI =  
-0.626614 to 
- 0.341297) 
Z(test d+ differs from 0) 
-3.103281      
P = 
0.0019 
-6.649008     
P < 0.0001 
Heterogeneity 
Cochran Q 
36.981816     
P < 
0.0001 
20.993852    
P = 0.0334 
I2 (inconsistency) 
86.5% 
(95% CI = 
70.4% to 
92%) 
47.6% 
(95% CI = 
0% to 
71.6%) 
Bias indicators 
Begg-Mazumdar:  
Kendall’s tau 
-0.6     P = 
0.0556 
-0.090909    
P = 0.6384 
Egger: bias 
-4.786308 
(95% CI = 
-
10.723268 
to 
1.150653) 
P = 
0.0888 
-0.59926  
(95% CI = -
2.64772 to 
1.4492) 
P = 0.5292 
 
Comparison of the pooled effect (D+) would suggest 
the superior efficacy of one treatment over the other, 
although as both sets of analysis yield significant 
overall effect (Z) it is not possible within the 
confines of this analysis to draw firm conclusions 
regarding which treatment regime is most effective. 
Discussion 
The meta analysis of drug and non drug data was 
carried out to investigate if alternative therapies are 
more effective than antidepressants for the treatment 
of depression in patients following brain injury. The 
results indicate that both treatment methods are 
effective with high significant values, however, as 
CIs of the two treatment methods overlap greatly, it 
cannot be said that one treatment option is better 
than the other. 
The research studies included in the meta analysis of 
non drug data have applied different treatment 
options such as; music therapy, cognitive 
behavioural therapy (CBT), psychotherapy and 
rehabilitation processes with coping mechanisms 
that have been shown to be effective in individual 
studies. The studies (Ashman et al, 2009; Fann, 
Uomoto and Katon, 2000; Lee et al, 2005) that are 
included in the meta analysis of drug data have 
mainly used antidepressants from the SSRI group. 
The choice of antidepressant drug is limited for 
managing depression in patients with brain injury 
due to the side effects of the pharmacological drug 
(Alderfer, Arciniegas and Silver, 2005; Berkow et 
al., 1997; Collier, Longmore and Scally, 2003). It is 
already established that people with brain injury are 
more prone to side effects due to imbalanced 
chemical reaction caused by the brain injury 
(Brown, 2004).  Pooled results of different non drug 
treatment methods used to manage depression 
indicate that alternative therapies are effective for 
the treatment of depression. The meta analysis 
results indicate that both antidepressants and non 
drug therapies are highly effective when used to 
treat depression in patients with brain injury, whilst 
the meta analysis result of both sets of data does not 
provide enough evidence to conclude that one 
treatment option is more effective than the other.  
However, individuals suffering from depressive 
disorder after brain injury report a preference for 
psychotherapy, behavioural therapy, physical 
exercise and counseling due to lack of side effects 
experienced with drug treatments (Fann et al, 2009). 
Evidence of the effectiveness of alternative therapies 
is reported here. This may be because depression in 
patients with brain injury is a secondary depression 
(Babin, 2003). Often people with brain injury have 
difficulty in performing daily routine activities and 
getting back into social life, which puts 
psychological pressure on individuals and they start 
falling into depression. Alternative therapies work 
effectively because people with brain injury learn 
how to cope and manage in social and daily life 
through CBT programs and psychotherapies, thus 
the efficacy of alternative therapies cannot be 
overlooked. This study of effectiveness of non drug 
therapies contributes to the growing debate of 
efficacy of alternative therapies that are applied to 
manage depression in patients with brain injury. The 
alternative therapies help bring about an 
improvement in an individual to function well in 
social, work and daily routine life. 
The research findings suggest that alternative 
therapies are as effective as drug treatment methods; 
alternative therapies can be used effectively to 
complement pharmacological treatment of 
depression in patients with brain injury. 
 Journal of Health and Social Care Improvement, 2015 September Issue  
6 
Furthermore, an individual can benefit from 
alternative therapy straight away whereas 
pharmacological treatment takes a minimum of two 
weeks before the effect can be appreciated. It has 
been established that people with brain injury are at 
higher risk of falling into depression due to the 
difficulty of functioning well in their routine life so 
alternative therapies with their various mechanisms 
of action can work alongside antidepressants to 
produce efficient results. Community based 
interventions such as those included in this meta 
analysis include volunteering (Ouellet, Morin and 
Lavoie, 2009),  community based outreach treatment 
from a multidisciplinary team involving clinicians, 
psychologists and social workers (Powell, Heslin 
and Greenwood , 2002), coping (Finest and 
Andersson, 2000), music therapy (Guetin et al, 
2009), and residential reintegration (Geurtsen et al, 
2008), and are delivered by a range of professionals 
with a variety of backgrounds and training.  As these 
are seen to be as effective as drug treatments they 
may be more acceptable to service users because 
barriers to accessing treatment such as location, fear 
of stigmatisation from having a psychiatric record 
and adverse side effects of drugs, are eliminated or 
minimised.  
A smaller number of studies on drug treatment 
method (6) than non drug treatment method (12) 
with different sample sizes within the studies is one 
of the limitations that might have affected the meta 
analysis results. Moreover, CI range and pooled 
effect size estimate values may vary with the 
number of studies included for meta analysis and 
different sample size of participants. The relatively 
small number of participants (total of 538) in the 
treatment group is another limitation noticed in this 
study because a small sample of participants may 
not provide perfect data analysis results. Moreover 
high levels of heterogeneity probably as a result of 
differing methodologies, treatments and outcome 
measures may have affected the results. Some of the 
researchers have used single and double blinding in 
their study whereas others have not used any 
blinding which is both a strength and a limitation 
and could be a source of bias for individual studies 
which could in turn impact the validity and 
reliability of the meta analysis. 
Conclusion 
Meta analysis results of drug and non drug data 
suggest that both treatment methods are effective 
when used to treat depression and aggregate results 
of meta analysis is supported with the findings of 
individual studies that report the effectiveness of 
treatment method used. The results of both sets of 
data are compared to investigate the research 
question of whether or not alternative therapies are 
an effective and superior mode of treating 
depression in patients with brain injury. After 
comparing the meta analysis results of drug and non 
drug data it is concluded that, although pooled effect 
size d+ value of drug and non drug data differ but 
95% CI range of both sets of data overlap, caution 
should be exercised in determining which treatment 
is superior.  
Interventions utilising both pharmaceutical and non 
pharmaceutical treatments based on patient need and 
accommodating preference should be developed. 
The use of community based treatments delivered 
and supported by independent and appropriately 
qualified individuals and community organisations is 
suggested. Within the current climate of providing 
care in the community, non drug treatments as 
included in this study and described above are to be 
encouraged. We suggest this not only because they 
are effective, acceptable and accessible, but they 
would by their nature involve self-employed or 
community employed practitioners as opposed to 
statutory service providers such as NHS and local 
government.   
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